{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:07:12Z","timestamp":1791450432363,"version":"4.3.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10633-025-10011-8","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T08:33:53Z","timestamp":1741768433000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Case of uveitis with increased electroretinographic amplitudes following Nivolumab and Ipilimumab administration for malignant melanoma"],"prefix":"10.1007","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-3443","authenticated-orcid":false,"given":"Kumiko","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryunosuke","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yonekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzen","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineo","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"10011_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L et al (2015) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372:320\u2013330","journal-title":"N Engl J Med"},{"key":"10011_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/09273948.2020.1773867","volume":"30","author":"D Bomze","year":"2022","unstructured":"Bomze D, Meirson T, Hasan Ali O, Goldman A, Flatz L, Habot-Wilner Z (2022) Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance Analysis. Ocul Immunol Inflamm 30:191\u2013197","journal-title":"Ocul Immunol Inflamm"},{"key":"10011_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160221","volume":"11","author":"N Abdel-Wahab","year":"2016","unstructured":"Abdel-Wahab N, Shah M, Suarez-Almazor ME (2016) Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports. PLoS ONE 11:e0160221","journal-title":"PLoS ONE"},{"key":"10011_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09273948.2019.1577978","volume":"28","author":"MdP Sun Mm","year":"2020","unstructured":"Sun Mm MdP, Levinson RM, Filipowicz AD, Anesi SM, Kaplan HM, Md WW, P, et al (2020) Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition. Ocul Immunol Inflamm 28:217\u2013227","journal-title":"Ocul Immunol Inflamm"},{"key":"10011_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12348-022-00321-2","volume":"13","author":"A Martens","year":"2023","unstructured":"Martens A, Schauwvlieghe PP, Madoe A, Casteels I, Aspeslagh S (2023) Ocular adverse events associated with immune checkpoint inhibitors, a scoping review. J Ophthalmic Inflamm Infect 13:5","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10011_CR6","doi-asserted-by":"publisher","unstructured":"Enomoto H, Kato K, Sugawara A, Itabashi M, Kondo M. (2021) Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment. Doc Ophthalmol;https:\/\/doi.org\/10.1007\/s10633-020-09800-0.","DOI":"10.1007\/s10633-020-09800-0"},{"key":"10011_CR7","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1167\/iovs.18-25087","volume":"59","author":"R Miyata","year":"2018","unstructured":"Miyata R, Kondo M, Kato K, Sugimoto M, Matsubara H, Ikesugi K et al (2018) Supernormal Flicker ERGs in Eyes With Central Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent. Invest Ophthalmol Vis Sci 59:5854\u20135861","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10011_CR8","doi-asserted-by":"publisher","unstructured":"Kato K, Sugawara A, Nagashima R, Sugimoto M, Ikesugi K, Matsubara H, et al. (2020) Case of lens-induced uveitis associated with supernormal flicker ERG amplitudes after cataract surgery. Doc Ophthalmol;https:\/\/doi.org\/10.1007\/s10633-020-09786-9.","DOI":"10.1007\/s10633-020-09786-9"},{"key":"10011_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/bjo.2004.047837","volume":"89","author":"GE Holder","year":"2005","unstructured":"Holder GE, Robson AG, Pavesio C, Graham EM (2005) Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br J Ophthalmol 89:709\u2013718","journal-title":"Br J Ophthalmol"},{"key":"10011_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ajo.2018.04.013","volume":"191","author":"W Yuan","year":"2018","unstructured":"Yuan W, Zhou C, Cao Q, Du Z, Hu R, Wang Y et al (2018) Longitudinal Study of Visual Function in Vogt-Koyanagi-Harada Disease Using Full-Field Electroretinography. Am J Ophthalmol 191:92\u201399","journal-title":"Am J Ophthalmol"},{"key":"10011_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100243","volume":"3","author":"K Kato","year":"2023","unstructured":"Kato K, Nagashima R, Matsubara H, Ikesugi K, Tsukitome H, Matsui Y et al (2023) Transient Increase of Flicker Electroretinography Amplitudes after Cataract Surgery: Association with Postoperative Inflammation. Ophthalmol Sci 3:100243","journal-title":"Ophthalmol Sci"},{"key":"10011_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12886-024-03484-9","volume":"24","author":"JN Wang","year":"2024","unstructured":"Wang JN, Zhang Y, Huang CY, Li K, Yu XB (2024) Development of Vogt-Koyanagi-Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report. BMC Ophthalmol 24:240","journal-title":"BMC Ophthalmol"},{"key":"10011_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2024.102670","volume":"53","author":"J Pedroso Lima","year":"2024","unstructured":"Pedroso Lima J, Ferreira AM, Quaresma V, Lopes M, Lorigo J, Azinhais P et al (2024) Immunotherapy-induced adverse events in metastatic renal cell carcinoma: A case of rapid response and complex challenges. Urol Case Rep 53:102670","journal-title":"Urol Case Rep"},{"key":"10011_CR14","volume":"15","author":"P Giannakis","year":"2023","unstructured":"Giannakis P, Malik M, Rashid S, Vrizidou E (2023) Unilateral Posterior Uveitis in a Patient Receiving Nivolumab for Malignant Melanoma. Cureus 15:e43311","journal-title":"Cureus"},{"key":"10011_CR15","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1038\/s41598-023-40565-z","volume":"13","author":"M Takeuchi","year":"2023","unstructured":"Takeuchi M, Meguro A, Nakamura J, Chikagawa R, Osada R, Shibuya E et al (2023) HLA-DRB1*04:05 is involved in the development of Vogt-Koyanagi-Harada disease-like immune-related adverse events in patients receiving immune checkpoint inhibitors. Sci Rep 13:13580","journal-title":"Sci Rep"},{"key":"10011_CR16","doi-asserted-by":"publisher","unstructured":"Brouwer AH, de Wit GC, Ten Dam NH, Wijnhoven R, van Genderen MM, de Boer JH. (2019) Prolonged cone b-wave on electroretinography is associated with severity of inflammation in non-infectious uveitis. Am J Ophthalmol;https:\/\/doi.org\/10.1016\/j.ajo.2019.05.028.","DOI":"10.1016\/j.ajo.2019.05.028"},{"key":"10011_CR17","doi-asserted-by":"publisher","first-page":"36591","DOI":"10.1038\/srep36591","volume":"6","author":"M Fukuo","year":"2016","unstructured":"Fukuo M, Kondo M, Hirose A, Fukushima H, Ikesugi K, Sugimoto M et al (2016) Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device. Sci Rep 6:36591","journal-title":"Sci Rep"},{"key":"10011_CR18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.exer.2010.08.014","volume":"91","author":"A Vielma","year":"2010","unstructured":"Vielma A, Delgado L, Elgueta C, Osorio R, Palacios AG, Schmachtenberg O (2010) Nitric oxide amplifies the rat electroretinogram. Exp Eye Res 91:700\u2013709","journal-title":"Exp Eye Res"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-025-10011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-025-10011-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-025-10011-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T01:23:46Z","timestamp":1749086626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-025-10011-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10011"],"URL":"https:\/\/doi.org\/10.1007\/s10633-025-10011-8","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}